Last reviewed · How we verify
Salonpas — Competitive Intelligence Brief
marketed
methyl salicylate
Immunology
Small molecule
Live · refreshed every 30 min
Target snapshot
Salonpas (METHYL SALICYLATE) — Hisamitsu Pharm Co.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Salonpas TARGET | METHYL SALICYLATE | Hisamitsu Pharm Co | marketed | methyl salicylate | 2008-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (methyl salicylate class)
- Hisamitsu Pharm Co · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Salonpas CI watch — RSS
- Salonpas CI watch — Atom
- Salonpas CI watch — JSON
- Salonpas alone — RSS
- Whole methyl salicylate class — RSS
Cite this brief
Drug Landscape (2026). Salonpas — Competitive Intelligence Brief. https://druglandscape.com/ci/methyl-salicylate. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab